Geron Corporation Stock Price, News & Analysis (NASDAQ:GERN)

$1.92 0.00 (0.00 %)
(As of 11/17/2017 04:00 PM ET)
Previous Close$1.92
Today's Range$1.88 - $1.93
52-Week Range$1.74 - $3.15
Volume1.25 million shs
Average Volume1.44 million shs
Market Capitalization$305.73 million
P/E RatioN/A
Dividend YieldN/A
Beta2.66

About Geron Corporation (NASDAQ:GERN)

Geron Corporation logoGeron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company is engaged in the development of therapeutic products for oncology. Using its nucleic acid chemistry, Geron designed Imetelstat to be an oligonucleotide that binds with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity. Janssen is engaged in the development of Imetelstat with two clinical trials, such as a Phase II trial in myelofibrosis (MF), referred to as IMbark, and a Phase II/III trial in myelodysplastic syndromes (MDS) referred to as IMerge. Imetelstat is a lipid conjugated 13-mer oligonucleotide that is designed to be complementary to and bind with high affinity to the RNA template of telomerase, thereby directly inhibiting telomerase activity.


Industry, Sector and Symbol:
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: Biotechnology
  • Sector: Bio Therapeutic Drugs
  • Symbol: NASDAQ:GERN
  • CUSIP: 37416310
  • Web: www.geron.com
Debt:
  • Current Ratio: 16.51%
  • Quick Ratio: 16.51%
Sales & Book Value:
  • Annual Sales: $6.16 million
  • Price / Sales: 49.63
  • Book Value: $0.68 per share
  • Price / Book: 2.82
Profitability:
  • Trailing EPS: ($0.18)
  • Net Income: ($29,530,000.00)
  • Net Margins: -2,992.67%
  • Return on Equity: -25.14%
  • Return on Assets: -23.29%
Misc:
  • Employees: 18
  • Outstanding Shares: 159,230,000
 

Frequently Asked Questions for Geron Corporation (NASDAQ:GERN)

What is Geron Corporation's stock symbol?

Geron Corporation trades on the NASDAQ under the ticker symbol "GERN."

How were Geron Corporation's earnings last quarter?

Geron Corporation (NASDAQ:GERN) announced its quarterly earnings data on Wednesday, November, 1st. The biopharmaceutical company reported ($0.04) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.05) by $0.01. The biopharmaceutical company had revenue of $0.16 million for the quarter, compared to the consensus estimate of $0.40 million. Geron Corporation had a negative net margin of 2,992.67% and a negative return on equity of 25.14%. The company's revenue was down 96.8% on a year-over-year basis. During the same period last year, the firm earned ($0.02) EPS. View Geron Corporation's Earnings History.

When will Geron Corporation make its next earnings announcement?

Geron Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, March, 7th 2018. View Earnings Estimates for Geron Corporation.

Where is Geron Corporation's stock going? Where will Geron Corporation's stock price be in 2017?

4 analysts have issued 12 month price objectives for Geron Corporation's shares. Their forecasts range from $2.50 to $5.00. On average, they anticipate Geron Corporation's share price to reach $4.17 in the next year. View Analyst Ratings for Geron Corporation.

Are investors shorting Geron Corporation?

Geron Corporation saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 27,766,039 shares, an increase of 2.0% from the October 13th total of 28,345,699 shares. Based on an average daily trading volume, of 1,368,377 shares, the short-interest ratio is presently 20.3 days. Currently, 17.5% of the company's shares are sold short.

Who are some of Geron Corporation's key competitors?

Who are Geron Corporation's key executives?

Geron Corporation's management team includes the folowing people:

  • Hoyoung Huh Ph.D., Independent Chairman of the Board (Age 48)
  • John A. Scarlett M.D., President, Chief Executive Officer, Director (Age 66)
  • Olivia K. Bloom, Chief Financial Officer, Executive Vice President - Finance, Treasurer (Age 46)
  • Stephen N. Rosenfield J.D., Executive Vice President, General Counsel and Corporate Secretary (Age 62)
  • Andrew J. Grethlein Ph.D., Executive Vice President - Development and Technical Operations (Age 50)
  • Melissa A. Kelly Behrs, Executive Vice President - Business Development and Portfolio and Alliance Management (Age 51)
  • Susan M. Molineaux Ph.D., Director (Age 63)
  • Daniel M. Bradbury, Independent Director (Age 56)
  • Karin Eastham CPA, Independent Director (Age 67)
  • V. Bryan Lawlis Jr. Ph.D., Independent Director (Age 65)

Who owns Geron Corporation stock?

Geron Corporation's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Russell Investments Group Ltd. (0.23%) and Raymond James Financial Services Advisors Inc. (0.05%). View Institutional Ownership Trends for Geron Corporation.

Who bought Geron Corporation stock? Who is buying Geron Corporation stock?

Geron Corporation's stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd. and Raymond James Financial Services Advisors Inc.. View Insider Buying and Selling for Geron Corporation.

How do I buy Geron Corporation stock?

Shares of Geron Corporation can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Geron Corporation's stock price today?

One share of Geron Corporation stock can currently be purchased for approximately $1.92.

How big of a company is Geron Corporation?

Geron Corporation has a market capitalization of $305.73 million and generates $6.16 million in revenue each year. The biopharmaceutical company earns ($29,530,000.00) in net income (profit) each year or ($0.18) on an earnings per share basis. Geron Corporation employs 18 workers across the globe.

How can I contact Geron Corporation?

Geron Corporation's mailing address is 149 Commonwealth Dr Ste 2070, MENLO PARK, CA 94025-1133, United States. The biopharmaceutical company can be reached via phone at +1-650-4737700 or via email at [email protected]


MarketBeat Community Rating for Geron Corporation (NASDAQ GERN)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  178 (Vote Outperform)
Underperform Votes:  137 (Vote Underperform)
Total Votes:  315
MarketBeat's community ratings are surveys of what our community members think about Geron Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Geron Corporation (NASDAQ:GERN)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 2 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $4.17 (117.01% upside)

Consensus Price Target History for Geron Corporation (NASDAQ:GERN)

Price Target History for Geron Corporation (NASDAQ:GERN)

Analysts' Ratings History for Geron Corporation (NASDAQ:GERN)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Needham & Company LLCReiterated RatingHoldN/AView Rating Details
11/3/2017Stifel NicolausReiterated RatingHold$2.50N/AView Rating Details
7/4/2017FBR & CoReiterated RatingBuyMediumView Rating Details
4/12/2017Piper Jaffray CompaniesReiterated RatingOverweight$5.00LowView Rating Details
9/20/2016BTIG ResearchReiterated RatingNeutralN/AView Rating Details
12/17/2015Janney Montgomery ScottInitiated CoverageBuy$6.50N/AView Rating Details
12/7/2015Oppenheimer Holdings, Inc.Reiterated RatingBuy$5.50N/AView Rating Details
(Data available from 11/17/2015 forward)

Earnings

Earnings History and Estimates Chart for Geron Corporation (NASDAQ:GERN)

Earnings by Quarter for Geron Corporation (NASDAQ:GERN)

Earnings History by Quarter for Geron Corporation (NASDAQ GERN)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2018        
11/1/2017Q3 2017($0.05)($0.04)$0.40 million$0.16 millionViewN/AView Earnings Details
8/9/2017Q2 2017($0.05)($0.04)$0.38 million$0.17 millionViewN/AView Earnings Details
5/9/2017Q1 2017($0.05)($0.05)$0.27 million$0.54 millionViewN/AView Earnings Details
3/1/2017Q416($0.06)($0.05)$0.18 million$0.09 millionViewListenView Earnings Details
11/3/2016Q316($0.06)($0.02)$0.22 million$5.10 millionViewListenView Earnings Details
8/3/2016Q216($0.07)($0.05)$0.38 million$0.21 millionViewListenView Earnings Details
5/5/2016Q116($0.06)($0.06)$0.26 million$0.74 millionViewListenView Earnings Details
2/25/2016Q415($0.05)($0.05)$0.32 million$0.22 millionViewListenView Earnings Details
11/5/2015Q315$0.11$0.17$17.87 million$35.40 millionViewListenView Earnings Details
8/5/2015Q2 15($0.06)($0.05)$0.40 million$0.25 millionViewN/AView Earnings Details
4/30/2015Q1($0.06)($0.06)$0.32 million$0.54 millionViewN/AView Earnings Details
3/3/2015Q4$0.17($0.06)$35.35 million$0.18 millionViewListenView Earnings Details
11/5/2014Q314($0.06)($0.06)$0.28 million$0.16 millionViewN/AView Earnings Details
8/11/2014Q214($0.06)($0.06)$0.22 million$0.34 millionViewListenView Earnings Details
5/1/2014Q114($0.06)($0.06)$0.35 million$0.47 millionViewListenView Earnings Details
3/27/2014($0.06)($0.07)ViewN/AView Earnings Details
3/17/2014Q413($0.07)($0.07)$0.35 millionViewListenView Earnings Details
11/7/2013Q313($0.06)($0.06)$0.49 million$0.18 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.07)($0.07)$0.50 million$0.11 millionViewListenView Earnings Details
4/25/2013Q1 2013($0.08)($0.09)$0.71 million$0.77 millionViewListenView Earnings Details
3/12/2013Q4 2012($0.14)($0.12)$0.50 million$0.69 millionViewListenView Earnings Details
10/30/2012Q312($0.14)($0.13)$0.38 million$0.64 millionViewN/AView Earnings Details
7/31/2012($0.15)($0.14)ViewN/AView Earnings Details
5/2/2012($0.18)($0.15)ViewN/AView Earnings Details
11/3/2011($0.18)($0.16)ViewN/AView Earnings Details
7/28/2011($0.18)($0.17)ViewN/AView Earnings Details
4/27/2011($0.19)($0.20)ViewN/AView Earnings Details
2/24/2011($0.19)($0.39)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Geron Corporation (NASDAQ:GERN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20171($0.06)($0.06)($0.06)
Q3 20171($0.06)($0.06)($0.06)
Q4 20171($0.06)($0.06)($0.06)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Geron Corporation (NASDAQ:GERN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Geron Corporation (NASDAQ GERN)

Insider Ownership Percentage: 7.10%
Institutional Ownership Percentage: 39.00%
Insider Trades by Quarter for Geron Corporation (NASDAQ:GERN)
Institutional Ownership by Quarter for Geron Corporation (NASDAQ:GERN)

Insider Trades by Quarter for Geron Corporation (NASDAQ GERN)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/29/2015Olivia Kyusuk BloomCFOSell2,380$3.84$9,139.20View SEC Filing  
3/18/2015Thomas HofstaetterDirectorSell70,000$4.10$287,000.00View SEC Filing  
5/29/2014Melissa Kelly BehrsEVPSell4,826$2.10$10,134.60View SEC Filing  
5/29/2014Olivia Kyusuk BloomCFOSell3,379$2.10$7,095.90View SEC Filing  
5/9/2014Daniel BradburyDirectorBuy142,776$1.75$249,858.00View SEC Filing  
4/1/2014Melissa Kelly BehrsEVPSell12,310$2.13$26,220.30View SEC Filing  
4/1/2014Olivia Kyusuk BloomCFOSell7,435$2.13$15,836.55View SEC Filing  
4/1/2013John A ScarlettCEOBuy50,000$1.03$51,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Geron Corporation (NASDAQ:GERN)

Latest Headlines for Geron Corporation (NASDAQ GERN)

Source:
DateHeadline
ETFs with exposure to Geron Corp. : November 17, 2017ETFs with exposure to Geron Corp. : November 17, 2017
finance.yahoo.com - November 17 at 5:36 PM
Today’s Research Reports on Trending Tickers: Gilead Sciences and Geron CorporationToday’s Research Reports on Trending Tickers: Gilead Sciences and Geron Corporation
finance.yahoo.com - November 16 at 2:41 PM
Geron Announces November Investor Conference Presentation WebcastsGeron Announces November Investor Conference Presentation Webcasts
finance.yahoo.com - November 8 at 7:54 AM
ETFs with exposure to Geron Corp. : November 6, 2017ETFs with exposure to Geron Corp. : November 6, 2017
finance.yahoo.com - November 7 at 12:52 AM
Stifel Nicolaus Reiterates Hold Rating for Geron Corporation (GERN)Stifel Nicolaus Reiterates Hold Rating for Geron Corporation (GERN)
www.americanbankingnews.com - November 4 at 6:42 PM
Needham & Company LLC Reaffirms Hold Rating for Geron Corporation (GERN)Needham & Company LLC Reaffirms Hold Rating for Geron Corporation (GERN)
www.americanbankingnews.com - November 3 at 11:58 PM
Geron Corp. :GERN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017Geron Corp. :GERN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017
finance.yahoo.com - November 3 at 10:23 AM
Geron (GERN) Q3 Loss Narrower Than Expected, Sales Miss - NasdaqGeron (GERN) Q3 Loss Narrower Than Expected, Sales Miss - Nasdaq
www.nasdaq.com - November 2 at 8:27 PM
Edited Transcript of GERN earnings conference call or presentation 1-Nov-17 8:30pm GMTEdited Transcript of GERN earnings conference call or presentation 1-Nov-17 8:30pm GMT
finance.yahoo.com - November 2 at 8:27 PM
Geron (GERN) Q3 Loss Narrower Than Expected, Sales MissGeron (GERN) Q3 Loss Narrower Than Expected, Sales Miss
finance.yahoo.com - November 2 at 8:27 PM
Geron Corp. – Value Analysis (NASDAQ:GERN) : November 2, 2017Geron Corp. – Value Analysis (NASDAQ:GERN) : November 2, 2017
finance.yahoo.com - November 2 at 8:27 PM
Geron Corporation (GERN) Given Average Recommendation of "Hold" by BrokeragesGeron Corporation (GERN) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 2 at 5:30 AM
Geron Corp (GERN) Tops Q2 EPS by 1c - StreetInsider.com - StreetInsider.comGeron Corp (GERN) Tops Q2 EPS by 1c - StreetInsider.com - StreetInsider.com
www.streetinsider.com - November 2 at 1:18 AM
Geron Corporations (GERN) CEO Dr. John Scarlett on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaGeron Corporation's (GERN) CEO Dr. John Scarlett on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 2 at 1:18 AM
EARNINGS SUMMARY: Details of Geron Corporation Q3 Earnings ReportEARNINGS SUMMARY: Details of Geron Corporation Q3 Earnings Report
www.rttnews.com - November 1 at 8:16 PM
Finally, Geron IMerges With Some Movement In MDSFinally, Geron IMerges With Some Movement In MDS
seekingalpha.com - November 1 at 8:16 PM
Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : November 1, 2017Geron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : November 1, 2017
finance.yahoo.com - November 1 at 8:15 PM
Geron (GERN) in Focus: Stock Moves 9.2% HigherGeron (GERN) in Focus: Stock Moves 9.2% Higher
finance.yahoo.com - November 1 at 8:15 PM
Geron Announces Presentations at American Society of Hematology Annual MeetingGeron Announces Presentations at American Society of Hematology Annual Meeting
finance.yahoo.com - November 1 at 8:15 PM
Geron Corporation to Host Earnings CallGeron Corporation to Host Earnings Call
finance.yahoo.com - November 1 at 8:15 PM
Geron Corporation Reports Third Quarter 2017 Financial ResultsGeron Corporation Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 1 at 8:15 PM
Geron reports 3Q lossGeron reports 3Q loss
finance.yahoo.com - November 1 at 8:15 PM
Geron Corporation (GERN) Issues  Earnings Results, Beats Estimates By $0.01 EPSGeron Corporation (GERN) Issues Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - November 1 at 5:28 PM
Geron Corp (GERN) Announces FDA Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic ... - StreetInsider.comGeron Corp (GERN) Announces FDA Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic ... - StreetInsider.com
www.streetinsider.com - November 1 at 1:13 AM
Geron Corp (GERN) Announces FDA Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic SyndromesGeron Corp (GERN) Announces FDA Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes
www.streetinsider.com - October 31 at 8:11 PM
Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic SyndromesGeron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes
finance.yahoo.com - October 31 at 8:11 PM
Why Geron Corporation Stock Is Jumping TodayWhy Geron Corporation Stock Is Jumping Today
www.fool.com - October 31 at 1:35 PM
Whats in the Cards for Geron (GERN) this Earnings Season?What's in the Cards for Geron (GERN) this Earnings Season?
finance.yahoo.com - October 28 at 4:27 AM
What's in the Cards for Geron (GERN) this Earnings Season?What's in the Cards for Geron (GERN) this Earnings Season?
finance.yahoo.com - October 28 at 4:27 AM
Geron Corporation (GERN) Set to Announce Earnings on WednesdayGeron Corporation (GERN) Set to Announce Earnings on Wednesday
www.americanbankingnews.com - October 26 at 1:18 PM
Geron Announces Conference Call to Discuss Third Quarter 2017 Financial ResultsGeron Announces Conference Call to Discuss Third Quarter 2017 Financial Results
feeds.benzinga.com - October 25 at 8:04 AM
ETFs with exposure to Geron Corp. : October 13, 2017ETFs with exposure to Geron Corp. : October 13, 2017
finance.yahoo.com - October 13 at 4:38 PM
Geron Corporation (GERN) Sees Significant Decrease in Short InterestGeron Corporation (GERN) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - October 13 at 1:32 AM
Analyzing Geron Corporation (GERN) and Its RivalsAnalyzing Geron Corporation (GERN) and Its Rivals
www.americanbankingnews.com - October 12 at 12:28 AM
Geron Corporation (GERN) Receives Average Rating of "Hold" from AnalystsGeron Corporation (GERN) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - October 8 at 4:50 AM
Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : October 4, 2017Geron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : October 4, 2017
finance.yahoo.com - October 4 at 11:41 AM
ETFs with exposure to Geron Corp. : October 2, 2017ETFs with exposure to Geron Corp. : October 2, 2017
finance.yahoo.com - October 2 at 2:11 PM
Contrasting Geron Corporation (GERN) & Its RivalsContrasting Geron Corporation (GERN) & Its Rivals
www.americanbankingnews.com - September 20 at 10:46 AM
Geron to Present at the Cantor Fitzgerald Healthcare Conference - GlobeNewswire (press release)Geron to Present at the Cantor Fitzgerald Healthcare Conference - GlobeNewswire (press release)
globenewswire.com - September 20 at 12:05 AM
Geron to Present at the Cantor Fitzgerald Healthcare ConferenceGeron to Present at the Cantor Fitzgerald Healthcare Conference
finance.yahoo.com - September 19 at 7:02 PM
ETFs with exposure to Geron Corp. : September 19, 2017ETFs with exposure to Geron Corp. : September 19, 2017
finance.yahoo.com - September 19 at 7:02 PM
Geron Corp. :GERN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017Geron Corp. :GERN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 18 at 6:34 PM
Geron Corporation (GERN) Given Consensus Rating of "Hold" by AnalystsGeron Corporation (GERN) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - September 13 at 4:48 AM
Geron Corporation (GERN) Sees Significant Drop in Short InterestGeron Corporation (GERN) Sees Significant Drop in Short Interest
www.americanbankingnews.com - August 27 at 4:28 AM
3 Top Biotech Stocks Under $53 Top Biotech Stocks Under $5
www.fool.com - August 19 at 4:26 PM
Geron Corporation (GERN) Given Consensus Recommendation of "Hold" by BrokeragesGeron Corporation (GERN) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - August 19 at 7:24 AM
Gerons (GERN) Imetelstat Progressing Well, Setbacks Concern - Yahoo FinanceGeron's (GERN) Imetelstat Progressing Well, Setbacks Concern - Yahoo Finance
finance.yahoo.com - August 16 at 12:40 AM
Gerons (GERN) Imetelstat Progressing Well, Setbacks ConcernGeron's (GERN) Imetelstat Progressing Well, Setbacks Concern
www.zacks.com - August 14 at 7:19 PM
Geron Corporation (GERN) Announces Quarterly  Earnings ResultsGeron Corporation (GERN) Announces Quarterly Earnings Results
www.americanbankingnews.com - August 11 at 9:38 PM
Geron (GERN) Q2 Loss Narrows, Sales Miss Estimates, Stock UpGeron (GERN) Q2 Loss Narrows, Sales Miss Estimates, Stock Up
finance.yahoo.com - August 10 at 11:34 PM

Social Media

Financials

Chart

Geron Corporation (NASDAQ GERN) Chart for Friday, November, 17, 2017
Loading chart…

This page was last updated on 11/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.